Tag Archives: Newslaundry

The matter of a journal’s reputation

Posted on August 8, 2020 by

Apparently (and surprisingly) The Telegraph didn’t allow Dinesh Thakur to respond to an article by Biocon employee Sundar Ramanan, in which Ramanan deems Thakur’s article about the claims to efficacy of the Biocon drug Itolizumab not being backed by enough data to have … Continue reading →

Posted in Analysis, Science | Tagged Biocon, Björn Brembs, COVID-19, cytokine release syndrome, Dinesh Thakur, Drug Controller General of India, Itolizumab, Jammi Nagaraj Rao, journal impact factor, Kiran Mazumdar-Shaw, Newslaundry, phase II clinical trials, phase III clinical trials, prestige journals, prestigious journals, reputed journals, Seema Ahuja, Sundar Ramanan, The Telegraph | Comments Off